Krystal Biotech, Inc. (KRYS) — DEF 14A Filings
All DEF 14A filings from Krystal Biotech, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Krystal Biotech Files DEF 14A, Details Executive Compensation
— Apr 3, 2025 Risk: medium
Krystal Biotech, Inc. filed its DEF 14A on April 3, 2025, detailing executive compensation and corporate governance for the fiscal year ending December 31, 2024 -
Krystal Biotech, Inc. Files Definitive Proxy Statement (DEF 14A)
— Apr 4, 2024 Risk:
Krystal Biotech, Inc. (KRYS) filed a Proxy Statement (DEF 14A) with the SEC on April 4, 2024. Krystal Biotech, Inc. filed a Definitive Proxy Statement (DEF 14A)
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX